Skip to content
zameds

Metronidazole

Schedule 2 to 4, conditions apply
Loading the molecular structure
C6H9N3O3171.15 g/mol

2-(2-Methyl-5-nitroimidazol-1-yl)ethanol

Drag to rotate. Structure from PubChem CID 4173.

Background

Loading...
Loading Wikipedia summary

Listing

Schedules
Schedule 2 to 4, conditions apply
Source
Consolidated Schedules 06 July 2026

Registered medicines

2 registered products listed

Counted through the register's ingredient index, which does not reach every record.

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
MetronidazoleEradia, Amzole, Dynametron, +41 more0,5 g, 1,0 g, 7.5 mg per g, 100 ml, +9 more24 applicants61 registrationsS4
Diloxanide furoate, metronidazoleEntamizoleNot statedAbbott Laboratories S.A. (Pty) LtdW0246S2 to S4conditions apply

Regulatory status

Where S2 to S4 sits on the scale

Depends on which listing applies

At the least restrictive, Schedule 2: a pharmacist can sell it directly, without a prescription. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.

Schedule S2 to S4, as the Consolidated Schedules list it.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Metronidazole

  • S4: Metronidazole

    • except intended and registered for use in pigeons in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947) and
    • except intended for human vaginal use, specifically for the treatment of recurrent bacterial vaginosis. (S2)

    Consolidated Schedules 06 July 2026, lines 7108 to 7117

  • S2: Metronidazole

    • when intended for human vaginal use, specifically for the treatment of recurrent bacterial vaginosis and except when intended and registered for use in pigeons in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947). (S4)

    Consolidated Schedules 06 July 2026, lines 2343 to 2345

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Research articles

Loading...
Loading PubMed articles